SEC 13F Intelligence

Flexion Therapeutics

CUSIP 33938J106

Flexion Therapeutics has 2 institutional holders in Filings Flow’s 13F database, together reporting 936.5K shares worth $6M as of Q4 2021.

Institutional Holders
2
Q4 2021
Reported Value
$6M
Ticker
unmapped
private placement or foreign
Quarters Tracked
6

Ownership Trend

Institutional holders
Q4 ’18: 102Q4 ’18Q1 ’19: 108Q1 ’19Q2 ’19: 105Q2 ’19Q3 ’19: 103Q3 ’19Q2 ’21: 123Q2 ’21Q4 ’21: 2Q4 ’21filingsflow.com
Total reported value
Q4 ’18: $215MQ4 ’18Q1 ’19: $461MQ1 ’19Q2 ’19: $400MQ2 ’19Q3 ’19: $659MQ3 ’19Q2 ’21: $1.3BQ2 ’21Q4 ’21: $6MQ4 ’21filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
MetLife Investment Management, LLC$19.6B AUM0.00%$204,06215.5KQ1 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.